Comparative Pharmacology
Head-to-head clinical analysis: NEO CORT DOME versus NEO SYNALAR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NEO CORT DOME versus NEO SYNALAR.
NEO-CORT-DOME vs NEO-SYNALAR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Neomycin is an aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. Hydrocortisone is a corticosteroid that exerts anti-inflammatory and immunosuppressive effects by binding to glucocorticoid receptors and modulating gene expression.
Neomycin (aminoglycoside) binds to bacterial 30S ribosomal subunit, inhibiting protein synthesis. Fluocinolone acetonide (corticosteroid) binds to glucocorticoid receptor, inducing anti-inflammatory proteins and suppressing inflammatory mediators.
Apply topically to affected area twice daily.
Apply a thin layer to affected area twice daily. Maximum 60 g per week.
None Documented
None Documented
2–3 hours (terminal elimination half-life of hydrocortisone); clinically, duration of action is longer due to intracellular receptor binding.
Approximately 2-4 hours for the corticosteroid component; clinical effect persists beyond due to cellular actions.
Renal excretion of hydrocortisone metabolites (primarily conjugated as glucuronides and sulfates) accounts for >90% of elimination; <5% biliary/fecal.
Renal (primarily as metabolites): ~80%; biliary/fecal: ~20%.
Category C
Category C
Corticosteroid with Antibiotic
Corticosteroid with Antibiotic